1.Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.
2.Sinclair K, Bogart A, Buchwald D, Henderson J. The prevalence of metabolic syndrome and associated risk factors in Northern Plains and Southwest American Indians. Diabetes care. 2011;34(1):118–20.
3.Souza LD, Berger H, Retnakaran R, Maguire J, Nathens A, Connelly P, et al. First-Trimester Maternal Abdominal Adiposity Predicts Dysglycemia and Gestational Diabetes Mellitus in Midpregnancy. Diabetes Care. 2016;39(1):61–4.
4.Lim S, Shin H, Song J, Kwak S, Kang S, Yoon JW, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 2011;34(6):1323–8.
5.Azimi-Nezhad M, Herbeth B, Siest G, Dadé S, Ndiaye N, Esmaily H, et al. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this?. Metab Syndr Relat Disord. 2012 10(3):181–8.
6.Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C. Metabolic syndrome in early pregnancy and risk of preterm birth. American journal of epidemiology. 2009;170(7):829–36.
7.Roberts C. IFPA Award in Placentology Lecture: complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta. 2010;31:47–53.
8.Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009;201(482):1–8.
9.Grieger J, Bianco-Miotto T, Grzeskowiak L, Leemaqz S, Poston L, McCowan L, et al. Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women. PLoS Med. 2018;4(15).
10.Mu P. Maternal role transition experiences of women hospitalized with PROM: a phenomenological study. Int J Nurs Stud. 2004;41(8):825–32.
11.Nagano N, Okada T, Yonezawa R, Yoshikawa K, Fujita H, Usukura Y, et al. Early postnatal changes of lipoprotein subclass profile in late preterm infants. Clin Chim Acta. 2012;18(413):109–12.
12.Noor S, Nazar A, Bashir R, Sultana R. Prevalance of PPROM and its outcome. J Ayub Med Coll Abbottabad. 2007;19(4):14–7.
13.James-Todd T, Wise L, Boggs D, Rich-Edwards J, Rosenberg L, Palmer J. Preterm birth and subsequent risk of type 2 diabetes in black women. Epidemiology. 2014;25(6):805–10.
14.Catov J, Wu C, Olsen J, Sutton-Tyrrell K, Li J, Nohr E. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20:604–9.
15.Bartha J, González-Bugatto F, Fernández-Macías R, González-González N, Comino-Delgado R, Hervías-Vivancos B. Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):178–84.
16.Alexander C, Landsman P, Teutsch S, Haffner S. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003 52(5):1210–4.
17.Biri A, Korucuoglu U, Ozcan P, Aksakal N, Turan O, Himmetoglu O. Effect of different degrees of glucose intolerance on maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2009 22(6):473–8.
18.Yun S, Han S, Lee S, Jung Y, Kim E. Comparison of Obstetric and Neonatal Outcomes According to Oral Glucose Challenge Test in Korean Pregnant Women. Korean Journal of Perinatology. 2013;24(3):180–6.
19.Basirat Z, Asnafi N, Kashifard M. Correlation between abnormal glucose challenge test and pregnancy outcomes. Journal Of Reproductive and Infertility 2010;11(2):113–19.
20.Catov J, Bodnar L, Ness R, Barron S, Roberts J. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312–9.
21.Hotamisligil G. Inflammation and metabolic disorders. Nature. 2006;14(444):860–7.
22.Catov J, Bodnar L, Kip K, Hubel C, Ness R, Harger G, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197(6):1–7.
23.Vrijkotte T, Krukziener N, Hutten B, Vollebregt K, Eijsden Mv, Twickler M. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab. 2012 97(11):3917–25.
24.Siahanidou T, Margeli A, Kappis A, Papassotiriou I, Mandyla H. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids. Metabolism. 2011;60(3):389–93.
25.Hubel C. yslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol. 1998;16(1):75–92.
26.Catov J, Nohr E, Olsen J, Ness R. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol. 2008 112(2):290–6.
27.Gilbert W, Young A, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med. 2007 52(11):1046–51.
28.Baliutavičienė D, Buinauskienė J, Petrenko V, Danytė E, Žalinkevičius R. Gestational diabetes, obesity, and metabolic syndrome diagnosed during pregnancy. Metab Syndr Relat Disord. 2012;10(3):214–7.
29.Lei Q, Niu J, Lv L, Duan D, Wen J, Lin X, et al. Clustering of metabolic risk factors and adverse pregnancy outcomes: a prospective cohort study. Diabetes Metab Res Rev. 2016 32(8):835–42.